Alphatec Holdings, Inc. ( ATEC ) NASDAQ Global Select

Cena: 11.3 ( 4.05% )

Aktualizacja 06-24 20:26
NASDAQ Global Select
Branża: Medical - Devices
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 839
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 67%
Ilość akcji: 136 301 000
Debiut giełdowy: 2006-06-12
WWW: https://www.atecspine.com
CEO: Mr. Patrick S. Miles
Adres: 1950 Camino Vida Roble
Siedziba: 92008 Carlsbad
ISIN: US02081G2012
Opis firmy:

Alphatec Holdings, Inc., firma zajmująca się technologią medyczną, projektuje, rozwija i rozwija technologie chirurgicznego leczenia zaburzeń kręgosłupa. Firma oferuje Safeop Neural Informatix System, platformę produktową Alpha Informatix zaprojektowaną w celu zmniejszenia ryzyka uszkodzenia nerwów śródoperacyjnych; Transforaminal Lędźwiowy system dostępu oparty na fuzji lędźwiowej, który zapewnia bezpośrednią wizualizację anatomicznych punktów orientacyjnych; System dostępu do Sigma PTP i system pozycjonowania pacjentów; Sypadron boczny wrodzenie zaprojektowane w celu maksymalizacji wyników pacjentów; Invictus kręgosłupa kręgosłupa, układ utrwalania klatki piersiowej do leczenia szeregu patologii; oraz system Invictus MIS Singlestep, który zapewnia minimalnie inwazyjne umieszczanie śruby szypułkowej. Zapewnia również modułowe systemy fiksacji Invictus zaprojektowane w celu zwiększenia zdolności adaptacyjnych przy mocy modułowości śrubowej; System osseoskrewa w celu przywrócenia integralności kolumny kręgosłupa; Arsenałowe system utrwalania kręgosłupa, kompleksowa platforma fiksacji klatki piersiowej w celu ustalenia zakresu patologii deformacji i procedur chirurgicznych; Aspida przednia układ posłania lędźwiowego, układ utrwalania przedniego fuzji międzywodowej lędźwiowej; Płyta przeciw migracyjnym AMP; OCT System utrwalania kręgosłupa; Lukse Lukse przedniego płyty szyjki macicy; i insygnia przednia system płyty szyjki macicy. Ponadto firma oferuje identyczne implanty rowerowe TI, Transcend Boczne i Batalion; i biologiczne składające się z strukturalnych przeszczepów szyjki macicy, obfitości 3D zdemineralizowanej rusztowania kości, neocore osteokondukcyjnej matrycy, alphagraft zdemineralizowanej i komórkowej matrycy kości oraz amnioshield amniotycznej bariery tkanki amniotycznej, a także produktów do obrazowania EOS. Sprzedaje swoje produkty za pośrednictwem sieci niezależnych dystrybutorów i bezpośrednich przedstawicieli handlowych w Stanach Zjednoczonych. Firma została założona w 1990 roku i ma siedzibę w Carlsbad w Kalifornii.

Wskaźniki finansowe
Kapitalizacja (USD) 1 651 754 900
Aktywa: 745 895 000
Cena: 11.3
Wskaźnik Altman Z-Score: -0.8
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -9.9
Ilość akcji w obrocie: 67%
Średni wolumen: 1 889 180
Ilość akcji 146 173 000
Wskaźniki finansowe
Przychody TTM 572 739 000
Zobowiązania: 747 257 000
Przedział 52 tyg.: 4.88 - 13.14
Piotroski F-Score: 3
Słaby (niska jakość finansowa)
EPS: -1.1
P/E branży: 26.8
Beta: 1.314
Raport okresowy: 2025-07-29
WWW: https://www.atecspine.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. David P. Sponsel Executive Vice President of Sales 960 845 1980
Mr. J. Todd Koning Executive Vice President & Chief Financial Officer 951 030 1973
Mr. Scott Lish Chief Operating Officer 723 205 1979
Mr. Patrick S. Miles Executive Chairman, Chief Executive Officer & President 1 790 393 1966
Mr. Craig E. Hunsaker Executive Vice President of People and Culture 1 135 735 1964
Mr. Eric Dasso Executive Vice President of Adjunctive Technologies 1 000 432 1973
Dr. Luiz Pimenta Chief Medical Officer 0 0
Mr. Tyson Eliot Marshall General Counsel & Corporate Secretary 0 1974
Mr. Jonathan Allen Executive Vice President of Commercial Operations 0 1960
Mr. Ali Shorooghi Senior Vice President of Marketing 0 1987
Wiadomości dla Alphatec Holdings, Inc.
Tytuł Treść Źródło Aktualizacja Link
Alphatec Holdings, Inc. (ATEC) Q1 2025 Earnings Call Transcript Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Matt Miksic - Barclays Mathew Blackman - Stifel Young Li - Jefferies Eric Anderson - TD Cowen David Saxon - Needham Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's First Quarter Financial Results. seekingalpha.com 2025-05-02 03:19:04 Czytaj oryginał (ang.)
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.34 per share a year ago. zacks.com 2025-05-01 23:06:04 Czytaj oryginał (ang.)
ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results   Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAA. businesswire.com 2025-05-01 20:05:00 Czytaj oryginał (ang.)
ATEC Launches PTP™ Corpectomy, The Next Evolution of Lateral Approach Surgery CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of its Prone TransPsoas (PTP™) Corpectomy system. This milestone marks the continued evolution of ATEC's PTP surgical approach, expanding its capabilities to include deformity and corpectomy procedures for complex pathologies of the thoracolumbar spine. “PTP Corpectomy represents a signific. businesswire.com 2025-04-21 13:00:00 Czytaj oryginał (ang.)
Alphatec Holdings: Business Has Reached An Inflection Point - Buy The Dip In recent years, Alphatec Holdings or "ATEC" has outperformed sales expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company continues to benefit from M&A-related disruptions at key competitors, which has created opportunities for ATEC to grab additional market share. Following years of elevated cash usage, the company managed to generate free cash flow in the final quarter of 2024. seekingalpha.com 2025-03-09 23:31:22 Czytaj oryginał (ang.)
ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from t. businesswire.com 2025-03-05 00:54:00 Czytaj oryginał (ang.)
Alphatec Holdings, Inc. (ATEC) Q4 2024 Earnings Call Transcript Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Phillip Dantoin - Piper Sandler Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Jason Wittes - ROTH David Saxon - Needham Kallum Titchmarsh - Morgan Stanley Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Fourth Quarter Financial Results. We would like to remind everyone that participants on the call will make forward-looking statements. seekingalpha.com 2025-02-27 09:30:45 Czytaj oryginał (ang.)
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.37 per share a year ago. zacks.com 2025-02-26 20:11:11 Czytaj oryginał (ang.)
ATEC to Participate in Upcoming Conferences CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Canaccord Genuity Musculoskeletal Conference in San Diego, CA, on March 10 2025, with a fireside chat at 10:30am PT The Barclays Global Healthcare Conference in Miami, FL, on March 11, 2025, with a fireside chat at 3:00pm ET If available. businesswire.com 2025-02-24 11:00:00 Czytaj oryginał (ang.)
Alphatec (ATEC) Moves 9.1% Higher: Will This Strength Last? Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. zacks.com 2025-01-14 09:16:14 Czytaj oryginał (ang.)
Wall Street Analysts Predict a 73.42% Upside in Alphatec (ATEC): Here's What You Should Know The consensus price target hints at a 73.4% upside potential for Alphatec (ATEC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2025-01-13 12:55:31 Czytaj oryginał (ang.)
ATEC to Present at the 2025 J.P. Morgan Healthcare Conference CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will present at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA, at 5:15pm PT on January 15, 2025. The webcast and the presentation materials will be available on the Investor Relations Section of the Company's website. About ATEC ATEC, through its wholl. businesswire.com 2024-12-09 11:00:00 Czytaj oryginał (ang.)
Alphatec Holdings, Inc. (ATEC) Q3 2024 Earnings Call Transcript Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Mathew Blackman - Stifel Matt Miksic - Barclays Matthew O'Brien - Piper Sandler Caitlin Cronin - Cannacord David Saxon - Needham Sean Lee - H.C. Wainwright Drew Ranieri - Morgan Stanley Operator Good afternoon, everyone. seekingalpha.com 2024-10-30 23:03:07 Czytaj oryginał (ang.)
Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates Alphatec (ATEC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.35 per share a year ago. zacks.com 2024-10-30 20:11:11 Czytaj oryginał (ang.)
ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2024, and recent corporate highlights. Third Quarter 2024 Financial Results   Quarter Ended September 30, 2024 Total revenue $151 million GAAP gross margin 68% Non-GAAP gross margin 69% GAAP operating expenses $136 million Non-GAAP operating expenses $114 mil. businesswire.com 2024-10-30 18:00:00 Czytaj oryginał (ang.)
ATEC to Report Third Quarter Financial Results on October 30, 2024 CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the. businesswire.com 2024-10-07 13:00:00 Czytaj oryginał (ang.)
3 Best Earnings Acceleration Stocks to Buy in a Strong Q4 With the advent of a strong fourth quarter, it's prudent to invest in stocks exhibiting solid earnings acceleration such as Argenx, Alphatec Holdings and Olin Corporation. zacks.com 2024-10-04 20:06:07 Czytaj oryginał (ang.)
Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024 24/7 Wall St. Insights With a market rotation underway, where should investors seeking opportunities in health care be looking? 247wallst.com 2024-08-22 13:15:33 Czytaj oryginał (ang.)
Alphatec Holdings, Inc. (ATEC) Q2 2024 Earnings Call Transcript Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2024 Results Conference Call July 31, 2024 4:30 PM ET Company Participants Patrick Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Matt Blackman - Stifel Drew Ranieri - Morgan Stanley Aaron Wukmir - Lake Street Capital Markets David Saxon - Needham & Co. Jason Wittes - ROTH Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Second Quarter Financial Results. seekingalpha.com 2024-08-01 00:13:05 Czytaj oryginał (ang.)
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates Alphatec (ATEC) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.43 per share a year ago. zacks.com 2024-07-31 22:16:11 Czytaj oryginał (ang.)
Alphatec's (ATEC) New EOS Insight System to Boost Spine Care Alphatec (ATEC) announces the commercial launch of its EOS Insight, an end-to-end spine surgery platform powered by standardized EOSedge scans and artificial intelligence. zacks.com 2024-07-25 17:01:04 Czytaj oryginał (ang.)
Wake Up! 3 Lesser-Known Stocks Investors Are Sleeping On One of the best ways to be successful in the stock market is by identifying under-the-radar stocks before they blow up. All of today's biggest and most valuable companies were once entirely unknown. investorplace.com 2024-06-10 13:00:00 Czytaj oryginał (ang.)
Alphatec Holdings, Inc. (ATEC) Q1 2024 Earnings Call Transcript Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Patrick Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Joshua Jennings - TD Cowen David Saxon - Needham Vik Chopra - Wells Fargo Sean Lee - H.C. Wainwright Young Li - Jefferies Operator Good afternoon everyone and welcome to the webcast of ATEC's First Quarter Financial Results. seekingalpha.com 2024-05-08 03:47:06 Czytaj oryginał (ang.)
ATEC to Present at Upcoming Conferences CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Bank of America Healthcare Conference at the Encore Hotel in Las Vegas, NV, on May 15, 2024, at 1:40pm PT The Barclays MedTech West Coast Bus Tour at the Fairmont Grand in Del Mar, CA, on May 20, 2024, at 8:00am PT The Wells Fargo West C. businesswire.com 2024-05-02 13:00:00 Czytaj oryginał (ang.)
ATEC to Report First Quarter Financial Results on May 7, 2024 CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2024 financial results on May 7, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live. businesswire.com 2024-04-17 13:00:00 Czytaj oryginał (ang.)
Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. “The addition of Emory adds even further con. businesswire.com 2024-04-04 13:05:00 Czytaj oryginał (ang.)
Shhh! 7 Small-Cap Stocks That Can Double by 2025 Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small. investorplace.com 2024-03-20 18:30:00 Czytaj oryginał (ang.)
3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio If you want big returns, you gotta think small – as in small-cap stocks. That's not to say the large-capitalization enterprises can't get you to investment Valhalla. investorplace.com 2024-03-10 17:24:03 Czytaj oryginał (ang.)
Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript seekingalpha.com 2024-02-28 01:01:08 Czytaj oryginał (ang.)
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates Alphatec (ATEC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago. zacks.com 2024-02-27 20:41:05 Czytaj oryginał (ang.)
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and full year ended December 31, 2023, and business highlights. Fourth Quarter and Full Year 2023 Financial Results Quarter EndedDecember 31, 2023 Year EndedDecember 31, 2023 Total revenues $ 138   $ 482   GAAP gross margin   69.0 %   64.3 % Non-GAAP gross margin (prior definiti. businesswire.com 2024-02-27 18:01:00 Czytaj oryginał (ang.)